Literature DB >> 3311534

Escherichia coli cellulitis in children with idiopathic nephrotic syndrome.

B I Asmar1, B N Bashour, L E Fleischmann.   

Abstract

Although Streptococcus pneumoniae is traditionally considered the preponderant bacterial pathogen in children with nephrotic syndrome, recent data suggest an increase of infections with encapsulated gram-negative organisms. We report two children with idiopathic nephrotic syndrome in relapse who developed spontaneous Escherichia coli cellulitis. The organism was recovered from the cellulitis tissue aspirate of one, and from the blood of the other. Both patients responded to appropriate antibiotic therapy. Initial treatment of sepsis, peritonitis or spontaneous cellulitis in nephrotic patients should include broad spectrum antibiotic coverage pending results of appropriate cultures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311534     DOI: 10.1177/000992288702601108

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

1.  Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.

Authors:  Ruaridh Buchanan; Nicole Stoesser; Derrick Crook; Ian C J W Bowler
Journal:  BMJ Case Rep       Date:  2014-10-19

2.  Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production.

Authors:  S P Chen; W Cheung; C K Heng; S C Jordan; H K Yap
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

3.  Gram-negative bacillary cellulitis in patients with hepatic cirrhosis.

Authors:  J M Corredoira; J Ariza; R Pallarés; J Carratalá; P F Viladrich; G Rufí; R Verdaguer; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

4.  Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.

Authors:  Cristina E Alcorta; Adam R Kronish; Matthew L Lorenz
Journal:  IDCases       Date:  2021-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.